We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+172.63%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$270M
AUM Growth
+$241M
Cap. Flow
+$154M
Cap. Flow %
57.06%
Top 10 Hldgs %
65.79%
Holding
91
New
53
Increased
2
Reduced
3
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 27.03%
2 Consumer Discretionary 15.45%
3 Communication Services 10.78%
4 Real Estate 4.6%
5 Financials 2.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
76
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
-5,197
Closed -$246K
DMK
77
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-48,542
Closed -$1.21M
AMRS
78
DELISTED
Amyris Inc.
AMRS
-112,639
Closed -$288K
NOVN
79
DELISTED
Novan, Inc. Common Stock
NOVN
-291,485
Closed -$435K
PTE
80
DELISTED
PolarityTE, Inc. Common Stock
PTE
-18,050
Closed -$487K
RESN
81
DELISTED
Resonant Inc.
RESN
-405,274
Closed -$600K
BXRX
82
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
-309
Closed -$1.07M
UUUU.WS
83
DELISTED
Energy Fuels Inc.
UUUU.WS
$0 ﹤0.01%
277,777
PSTVZ
84
DELISTED
PLUS THERAPEUTICS, Inc. Series S Warrant
PSTVZ
-259,200
Closed -$2K
BNTCW
85
DELISTED
Benitec Biopharma Limited
BNTCW
-50,000
Closed -$2K
BLPH
86
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-19,200
Closed -$210K
MCF
87
DELISTED
Contango Oil & Gas Co.
MCF
-91,120
Closed -$137K

Similar funds

CVI Holdings's Q2 2020 Portfolio in Review

As of Q2 2020, CVI Holdings held 91 positions worth $270M, up 847% from $28.5M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

CVI Holdings deployed $154M of net new capital in Q2 2020, opening 53 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Enlivex Ltd, an estimated $1.96M trimmed.

  • CVI Holdings's largest Q2 2020 buy was Nikola Corporation Common Stock: 16,667 shares worth $33.8M.
  • CVI Holdings added most to Replimune Group in Q2 2020, an estimated $2.26M increase.
  • CVI Holdings's biggest Q2 2020 reduction was Enlivex Ltd, cutting an estimated $1.96M.
  • CVI Holdings fully exited DMK Pharmaceuticals Corporation Common Stock in Q2 2020, selling an estimated $1.21M.
  • CVI Holdings's ten largest holdings make up 66% of its $270M portfolio in Q2 2020.
  • CVI Holdings opened 53 new positions and closed 21 in Q2 2020.
  • CVI Holdings's portfolio value rose 847% quarter-over-quarter to $270M.

Based on CVI Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.